Frances is joining Orphan Drug Consulting as a Supply Chain Consultant. She is a leading expert in supply chain with a proven ability to deliver results through her significant technical expertise coupled with her project management, and client relationship management abilities. She specialises in supply chain leadership, vendor management, project management, and country-specific product launches and routes to market for clients in multiple regions. Her extensive experience will be directly applicable to the needs of both new and existing clients of Orphan Drug Consulting.
Frances has over 18 years of experience working in the pharmaceutical industry, having held roles in supply chain management, logistics, and project management in a wide range of companies. As part of these roles, she developed new strategies, business models, processes, technologies, and systems required to support launching products into the EMEA. Frances most recently held the position of Global Trade and Customs Director in Mylan Pharmaceuticals.
Frances holds a Master of Science in Supply Chain Management from Technological University Dublin and is a Prince 2 Certified Practitioner.
Donal O’Grady is joining Orphan Drug Consulting as a Supply Chain Consultant with over 25 years of experience in the Life Science industry, having previously held roles in procurement, operations and supply chain, and business development. Donal has a wealth of experience in operational excellence in global organisations and has a proven track record of delivering cost improvement, employing lean principles, and implementing organisational change management programs.
He has held senior positions in Wyeth, Bristol-Myers Squibb, Zoetis, and most recently Senior Director of CMO Operations at BioMarin Pharmaceutical developing both internal and external operations for small and large molecules. As part of his role in Orphan Drug Consulting, Donal will specialise in helping organisations achieve optimal external supply solutions, managing supplier relationships, and creating value through a virtual pharma model.
Donal holds a Bachelor of Science degree in Biotechnology from Dublin City University (DCU). Additionally, Donal has a Post Graduate ACCA Certified Diploma in Accounting and Finance from Dublin Business School (DBS). Donal is also certified in the Six Sigma Black belt.
Adding Frances and Donal’s wealth of applicable experience facilitates Orphan Drug Consulting continued growth and is synergistic to the company’s overall value proposition.
Evelyn Kelly, Managing Director of Orphan Drug Consulting commented on Frances and Donal joining: “It’s a pleasure to welcome both Frances and Donal to the team. Between them, their wealth of experience speaks volumes which will facilitate our ongoing growth and let us continue to meet our clients’ needs effectively. I look forward to working closely with them both as Orphan Drug Consulting continues to grow.”
Frances adds: “I am delighted to be one of a growing number of consultants joining the Orphan Drug Consulting team. I look forward to supporting the expert team and working alongside new and existing clients to guide them through the product launch process”.
Donal adds: “I am excited to join Orphan Drug Consulting as it continues to grow globally. I look forward to providing strategic advice to clients and guiding them through the supply chain process to ensure patient’s needs are met”.
About Orphan Drug Consulting Ltd
Orphan Drug Consulting coordinate product launch into the US, EU, and other international markets providing strategic support in the areas of supply chain, quality assurance, vendor management, and entity management with its team of experienced industry professionals. From full-service solutions to solving specific immediate requirements, Orphan Drug Consulting is your partner of choice to manage market complexities ensuring your successful product launch to meet your patients’ needs.